123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> Health >> View Article

Chinese Healthcare Market Maintains A Growth Rate Of 16 Percent In Recent Years.

By Author: Aarkstore Market Research
Total Articles: 96

China is one of the fastest growing global economies with a one-fifth population in the world. Nowadays, China has become the worlds second largest healthcare market after the United States. Along with sustained economic and population growth, and rapid population aging, the Chinese healthcare market has maintained an annual compound growth rate above 16 % since the 2010s. The statistical data showed that the scale of the Chinese healthcare market has reached RMB 6464.1 billion (about equivalent to US$973.5 billion) by 2017. Among them, the total value of medical device sales was RMB 663.2 billion (US$95.2 billion) with the annual compound growth rate of 20.27% by 2017. Medical devices have been widely used in the process of disease prevention, diagnosis, therapy, care, and rehabilitation.

However, large and medium-sized medical devices, high-end medical equipment and high-value medical materials are mainly relying on imported, such as the high-tech and high-valued imaging systems and navigation and positioning systems. Facing a gigantic population and rapid population aging, the Chinese government, on one side, accelerated the priority approval of innovative medical devices and relaxed the market access for overseas medical devices, on another side, intensified the supervision and administration for medical devices at the post—marketed. In recent years, China’s fast-track approval time is much shorter than any other country, which attracts more and more overseas medical device manufacturers to enter the Chinese healthcare market. Undoubtedly the Chinese healthcare market of nearly 1.4 billion populations is the huge business opportunities for the overseas medical device manufacturers.

At the same time, the Chinese regulatory authorities are changing regulatory framework to intensify the supervision and administration. The Chinese “State Administration for Market Regulation” and the “National Health Commission” jointly issued the latest version of “Measures for Medical Device Adverse Event Monitoring and Re-evaluation” in August 2018, which has been implemented on January 1, 2019. This is a challenge to overseas medical device manufacturers. To capture the huge business opportunities of the Chinese healthcare market and seize a larger part of the Chinese healthcare market, how do the foreign medical device manufacturers in compliance with the latest Chinese regulations on medical devices? How do the overseas medical device manufacturers operate business smoothly in China? Most importantly, overseas and multinational medical device manufacturers should always stand ready to respond to further regulation and policy changes occurred in China.

The overseas and multinational medical device manufacturers and their senior executive officers engaging in regulatory affairs need a thorough knowledge of the Chinese regulations for medical device adverse event reporting, monitoring and re-evaluation. China’s regulatory approach and culture are unique.

Latest Chinese Guidebook for Medical Device Adverse Events Reporting, Monitoring and Re-Evaluation (2019 Edition) is an essential resource for overseas and multinational medical device manufacturers to handle the medical device adverse event reporting, monitoring and re-evaluation smoothly in China, which provided a detailed guidance of comprehensive and thorough knowledge of the Chinese medical device adverse event reporting, monitoring and re-evaluation regulations.

This guidebook is organized as follows:
Chapter 2 provides a brief description of China’s healthcare market landscape and rapidly changing regulatory framework as a background for the audience.
Chapter 3 introduces the general regulations for medical device adverse event reporting, monitoring, and re-evaluation.
Chapter 4 introduces the Chinese regulatory authorities and their respective functions and the Chinese huge medical device adverse event monitoring information network.
Chapter 5 expounds the marketing authorization holders’ duties and obligations, which is important for the overseas and multinational medical device manufacturers and the agents within the territory of China designated by the overseas medical device manufacturers because they must fulfill these duties and obligations that are stipulated by the Chinese regulatory authorities.
Chapter 6 expounds the medical device distributors’ and medical device user facilities’ duties and obligations, which is important for the distributors within the territory of China of the overseas and multinational manufacturers of imported medical devices because they must also fulfill their duties and obligations that are stipulated by the Chinese regulatory authorities.
Chapter 7 elaborates the medical device adverse event reporting and evaluation, from the basic requirements, the different types of medical device adverse event reporting, and the time limitations for different types of medical device adverse event reporting to an entire process of medical device adverse event reporting, which is important for the overseas and multinational manufacturers of imported medical devices and the agents within the territory of China designated by the overseas medical device manufacturers, because they must be in compliance with these regulations.
Chapter 8 introduces how Chinese regulatory authorities implement key monitoring of certain medical devices.
Chapter 9 elaborates that the marketing authorization holders should adopt what risk control measures under what circumstances and report to the drug regulatory authorities.
Chapter 10 elaborates that the marketing authorization holders should proactively conduct the re-evaluation under what circumstances and report to the drug regulatory authorities.
Chapter 11 introduces that the Chinese regulatory authorities will carry out the focusing inspections on the marketing authorization holders under what circumstances.
Chapter 12 describes and sketches a panoramic view of the Chinese network for medical device adverse event reporting and monitoring.

The audiences of this guidebook are the overseas medical device companies wishing to enter into the Chinese medical device market, and the multinational medical device companies have penetrated into the Chinese medical device market, and their senior executive officers engaging in regulatory affairs expecting to understand the latest Chinese regulations on medical device adverse events reporting, monitoring and re-evaluation.

After having skimmed through this guidebook, audiences can clearly acquire a comprehensive and thorough knowledge of the latest Chinese regulations on medical device adverse events reporting, monitoring and re-evaluation. This guidebook, based on the full and accurate regulations, can guide overseas and multinational medical device manufacturers to achieve a successful entry into the Chinese medical device market, and smoothly operate their companies in China.

Reasons To Buy
The Chinese “State Administration for Market Regulation” and the “National Health Commission” jointly issued the latest version of “Measures for Medical Device Adverse Event Monitoring and Re-evaluation” in August 2018, which has been implemented on January 1, 2019.

This is a challenge to overseas medical device manufacturers. To capture the huge business opportunities of the Chinese healthcare market and seize a larger part of the Chinese healthcare market, how do the foreign medical device manufacturers in compliance with the latest Chinese regulations on medical devices? How do the overseas medical device manufacturers operate business smoothly in China? Most importantly, overseas and multinational medical device manufacturers should always stand ready to respond to further regulation and policy changes occurred in China. The overseas and multinational medical device manufacturers and their senior executive officers engaging in regulatory affairs need a thorough knowledge of the Chinese regulations for medical device adverse event reporting, monitoring and re-evaluation. China’s regulatory approach and culture are unique.

Latest Chinese Guidebook for Medical Device Adverse Events Reporting, Monitoring and Re-Evaluation (2019 Edition) is an essential resource for overseas and multinational medical device manufacturers to handle the medical device adverse event reporting, monitoring and re-evaluation smoothly in China, which provided a detailed guidance of comprehensive and thorough knowledge of the Chinese medical device adverse event reporting, monitoring and re-evaluation regulations.

Report Highlights
• A brief description for China’s healthcare market landscape and rapidly changing regulatory framework that let the overseas and multinational medical device manufacturers clearly understand the present-day realities of the Chinese healthcare market landscape and rapidly changing regulatory framework, and tell the overseas and multinational medical device manufacturers the opportunities and challenges.
• The Chinese regulatory authorities at various administrative levels and their respective functions and the Chinese huge medical device adverse event monitoring information network.
• The detailed Chinese regulations for the marketing authorization holders’ duties and obligations that are important for the overseas and multinational medical device manufacturers and the agents within the territory of China designated by the overseas medical device manufacturers, because they must fulfill these duties and obligations that are stipulated by the Chinese regulatory authorities.
• The detailed Chinese regulations for the medical device distributors’ and medical device user facilities’ duties and obligations that are important for the distributors within the territory of China designated by the overseas and multinational manufacturers exporting medical device products to China, because they must also fulfill their duties and obligations that are stipulated by the Chinese regulatory authorities.
• The detailed Chinese regulations for the medical device adverse event reporting and evaluation, from the basic requirements, the different types of medical device adverse event reporting, and the time limitations for different types of medical device adverse event reporting to an entire process of medical device adverse event reporting to smoothly navigate complex regulatory requirements step by step, which is important for the overseas and multinational manufacturers of imported medical devices and the agents within the territory of China designated by the overseas medical device manufacturers, because they must be in compliance with these regulations.
• The detailed description of how Chinese regulatory authorities implement the key monitoring on certain medical devices.
• The detailed guidelines for the marketing authorization holders of the overseas and multinational medical device manufacturers exporting medical device products to China, they should adopt what risk control measures under what circumstances and report to the drug regulatory authorities to smoothly navigate complex regulatory requirements step by step.
• The detailed guidelines for the marketing authorization holders of the overseas and multinational medical device manufacturers exporting medical device products to China, they should proactively conduct the re-evaluation under what circumstances and report to the drug regulatory authorities to smoothly navigate complex regulatory requirements step by step.
• The detailed introduction for the Chinese regulatory authorities will carry out the focusing inspections on the marketing authorization holders under what circumstances.
• An overview of a Chinese monitoring network for medical device adverse event reporting and monitoring , which covers the detailed regulatory authorities at various administrative levels and their functions, and the complete picture of Chinese monitoring network for medical device adverse event reporting and monitoring to provide a direction of gateway for medical device adverse event reporting and monitoring.

Category: Healthcare
Related Reports:
Latest Chinese Guidebook for Regulations on the Administration of Overseas Inspection for Imported Drugs and Medical Devices (2019 Edition)

Contact Details:
Aarkstore Enterprise
24/7 Online Support: +91 9987295242 | contact@aarkstore.com

Total Views: 19Word Count: 1677See All articles From Author

Health Articles

1. Teeth Stains: What You Need To Know?
Author: Joshua Su

2. For What Reason Is The Interest For An Enhancement On The Ascent ?
Author: nancy smith

3. How Can I Order Tramadol Online In Cheapest Price?
Author: Best Pharmacy Market

4. How Do Supplements Affect Human Life?
Author: vitasave.ca

5. When To Consult A Counsellor And Why
Author: Lewis Thornton

6. Benefits Of Taking Up Training In Reformer Pilates
Author: Holly Coane

7. Is Tapentadol 100mg Habit-forming As Tramadol 100mg Pills
Author: Is TapenTadol 100mg habit-forming as Tramadol 100m

8. Phases And Importance Of Hcg Diet Plan
Author: OrganicaUSA

9. Buy Tramadol 100 Mg Online With Cod | Tramadol Online No Prescription
Author: Buy Tramadol 100 MG Online with COD | Tramadol COD

10. Few Reasons To Get A Medical Marijuana Card Saint Petersburg, Florida
Author: kevin Joseph

11. Ayurvedic Treatment A Superlative Way To Relieve Nephrotic Syndrome
Author: Karma Ayurveda

12. Why To Incorporate Chinese Herbal Medicine In Daily Life
Author: Seth Aslatt

13. How Learning To Adapt To Disability Can Take Time And Courage
Author: Derry Hall

14. Dental Implants – All You Need To Know!
Author: Nisha Dhankhar

15. Why Is Botox Treatment Needed?
Author: Cosmetic Surgeon San Antonio

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: